Xacduro

sulbactam, durlobactam

Approval

ApplicationNDA 216974
Approval dateMay 23, 2023
Approval year2023
SponsorEntasis Therap

FDA-approved use

To treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Xacduro: